after an infarction [14, 32, 33] . Although data from the 1970s suggested about a 30% risk of reinfarction or cardiac death with surgery within 3 months of a previous myocardial infarction and a 15% risk with surgery within 3-6 months after a previous myocardial infarction [14, 32, 33] , more recent studies using invasive haemodynamic monitoring and modern anaesthetic care have reported much lower complication rates. Wells and Kaplan [35] reported on 48 patients who had surgery within 3 months after a myocardial infarction and who had no reinfarctions. Rao, Jacobs and El-Etr [28] reported a 6% rate of reinfarction for surgery within 3 months after a preoperative myocardial infarction and a 2 % rate of reinfarction for surgery within 3-6 months after myocardial infarction. These data suggest that rates of reinfarction and cardiac death may be substantially lower in the 1980s than they were in the 1970s, if carefully selected patients with recent preoperative myocardial infarctions have modern monitoring and anaesthetic care.
The timing of surgery after a recent preoperative myocardial infarction requires careful consideration of the patient's functional status and of both the urgency and the likely risks and benefits of the surgical procedure. If a procedure is life-saving, it must be performed regardless of the cardiac risk. Conversely, purely elective procedures may be delayed until the patient's cardiac risk has returned to its lowest possible level, which most experts believe entails a full 6 months after the infarction.
For many patients, however, the non-cardiac surgery is neither urgently life-saving nor purely elective. In patients who have a potentially resectable malignancy or who have other serious conditions, such as severe symptomatic peripheral vascular disease, one would like to delay surgery until it is safe, but not wait a full 6 months after the myocardial infarction. A rational approach to such patients is as follows. Scar formation after a myocardial infarction usually occurs within 4-6 weeks. At that time, the patient's functional capacity can be evaluated with studies such as a submaximal exercise tolerance test [5] . If the patient is symptomatic on minimal exercise or has major electrocardiographic changes during exercise, cardiac catheterization and subsequent consideration of revascularization is recommended. If the patient does well after the infarction and has good exercise capacity, one can consider proceeding with the non-cardiac sugery at approximately 6 weeks after the myocardial infarction. However, non-cardiac surgery should be delayed in patients who have important post-infarction angina, large reversible defects on thallium scintigraphy, marked ST-segment depression with exercise, or other evidence of severe ischaemia. Such patients should normally undergo coronary arteriography and revascularization before all but emergency surgery.
In the patient with chronic stable angina, it is vital to determine the patient's exercise tolerance in addition to the frequency of angina. Paradoxically, patients who have heart disease may report less frequent angina if their functional status declines because of serious non-cardiac conditions, such as orthopaedic or peripheral vascular disease [16, 17] . Thus, patients should be asked if they can perform common activities that might imply that their functional status is Class II or better, such as carrying grocery bags or any 10-15 kg object up a flight of stairs without developing appreciable symptoms or having to stop. Patients who have Class I or Class II angina using such criteria can commonly increase their heart rates and arterial pressures into the range that would be expected with well-controlled anaesthesia and surgery. Conversely, if patients cannot perform such activities because of symptoms of ischaemic heart disease, further evaluation is warranted.
In selecting tests for further evaluation, special attention must be given to the patient's particular characteristics. Exercise treadmill testing can assess both the patient's exercise tolerance and also his/her probability of ischaemic heart disease. Although exercise tests are not perfectly accurate for diagnosing the presence or absence of ischaemic heart disease, they are extremely useful for assessing functional status. Thus, patients who can perform at least five metabolic equivalents of exercise appear less likely to develop postoperative death or myocardial infarction than patients who cannot [3] , and patients older than 65 yr who cannot perform 2 min of supine bicycle exercise and raise their heart rates above 99 beat min" 1 also appear to be at higher risk (table I) [10] .
Poor left ventricular function, as demonstrated by either echocardiography or radionuclide ventriculography, can identify patients who are at higher risk of complications. However, such tests at rest do not provide functional information and may not identify patients in whom potential interventions are likely to change risk.
The most difficult clinical subset are those patients who are unable to exercise because of non-cardiac conditions such as peripheral vascular disease or orthopaedic conditions. In such patients, dipyridamole-thallium imaging is potentially useful (table II) [1, 20, 24] . The highest risk group appears to be patients who have underlying symptoms and who also have reversible defects on thallium imaging (table III) [8] . The principal limitation of dipyridamole-thallium imaging is that it demonstrates anatomical abnormalities without necessarily giving a clear indication of the physiological severity. If a physiological test is needed, right atrial pacing can be combined with thallium imaging and haemodynamic measurements to assess the patient's response to tachycardia [18] . Despite its limitations, dipy- Dipyridamole-thallium scanning patients [1, 24] • thallium ridamole-thallium imaging appears to be a potentially useful way to evaluate patients in whom other non-invasive tests are not helpful. Ambulatory ischaemia monitoring is another potential means for detecting ischaemia in patients who are unable to exercise. Early data suggest that patients who have ischaemia on monitoring are more likely to have cardiac events during followup [29] , but it is too early to know the precise role for ambulatory monitoring in selecting patients for surgery.
Cardiac catheterization is indicated before all but truly emergency surgery in patients who would normally be candidates for coronary artery bypass grafting based on the severity of their symptoms. Coronary angiography should also be considered in patients who are identified as having Class III or more severe angina during the preoperative evaluation, and in symptomatic patients who have markedly positive exercise treadmill tests, transient defects on dipyridamolethallium scanning, or who are at high risk because of recent myocardial infarctions or other combinations or risk factors (see Multifactorial Assessment of Risk).
Patients who have had previous coronary revascularization can undergo subsequent noncardiac surgery with low mortality rates [19, 22, 25] , except perhaps in the first 30 days after the revascularization [4] . In the Coronary Artery Surgery Study Registry of patients who had mild stable angina or who were asymptomatic after a myocardial infarction [9] , total operative mortality for major non-cardiac surgery was 0.9% in patients who had coronary revascularization before the non-cardiac surgery and 2.4% among patients who had the major non-cardiac surgery without preceding coronary artery surgery. However, if one considers the average 1.4 % mortality from the coronary revascularization, the total mortality in the two groups was similar. Furthermore, the risk of perioperative myocardial infarction at the time of the non-cardiac surgery was not different in the two groups.
Although early investigators expressed concern on the safety of anti-anginal medications, especially beta-blockers, in the perioperative period, subsequent data have emphasized the safety of continuing such medications and the dangers of sudden discontinuation [2, 12, 23] . Beta-blockers diminish the risk of severe hypertension or ischaemia during intubation, anaesthesia and surgery [26, 27] . In general, anti-anginal medication should be continued up to and often including the morning of surgery and recommenced as soon as possible after operation. For patients with important angina, propranolol can be given i.v. according to several well-documented regimens [31, 36] . Since beta-blockers, even propranolol, have a tissue half-life of approx. 24 h, i.v. medications should not be required in the operating theatre and usually need not be started until at least a day after they have been discontinued orally.
There are no convincing data to indicate any major clinical cardiac complications from the use of calcium channel antagonists in the perioperative period. Nifedipine may be given sublingually, and nitrates may be give sublingually, 
Intraoperative monitoring
In patients with severe heart disease, careful intraoperative monitoring, including intraarterial pressure recordings and pulmonary artery catheterization, appear to be helpful [35, 28] . It is difficult at this time, however, to establish definitive guidelines as to exactly which patients should receive such invasive monitoring. Nevertheless, more aggressive intraoperative procedures have been associated with lower risks of perioperative myocardial infarction [35, 28] . Thus, a major area for future investigation will be to determine which type of patients are likely to have a cost-effective benefit from such expensive and invasive monitoring techniques.
Multifactorial assessment of risk
My colleagues and I have previously reported on a multifactorial index that incorporates several pieces of information from the history, physical examination and laboratory to estimate a patient's overall risk of major cardiac complications (table IV) [13] . More recently, a revised version of the original index was proposed and shown to be equally good when evaluated in one institution (table V) [6, 7] . The original multifactorial index (table IV) has been evaluated more widely [7, 10, 21, 22, 34, 37] , and it appears able to provide prognostic stratification in a wide variety of settings (table VI) . By considering three different types of patient and planned surgical procedures, a patient's score on the multifactorial index can be integrated with this information to provide a well-validated likelihood of major cardiac complications (table VII) .
Type of anaesthesia
There are currently no data to document that the choice of the type of anaesthesia is a major correlate of perioperative clinical cardiac complications. There appears to be no benefit from spinal compared with general anaesthesia, probably because unplanned intraoperative hypotension is as likely with spinal anaesthesia as with general anaesthesia. 
Postoperative considerations
Studies from the 1970s consistently showed that most postoperative myocardial infarctions occurred within 6 days after surgery, with a peak around the 3rd day after operation [30] . More recent preliminary data, however, suggest that many smaller non-Q wave infarctions may occur much earlier during the postoperative period and may be detectable by continuous electrocardiographic monitoring and frequent sampling of creatine kinase isoenzymes. At least 50% of postoperative myocardial infarctions are painless, and many such infarctions present with otherwise unexplained alterations in vital signs or mental status [15, 30] .
SUMMARY
The perioperative care of the patient with known or suspected ischaemic heart disease requires careful co-ordination among the anaesthetist, surgeon and medical consultant. Careful preoperative evaluation can aid the identification of risk, the selection of preoperative interventions that may reduce risk, and decisions on intraoperative and postoperative monitoring. Although uncontrolled observational data suggest that such careful management allows for improved outcome, more carefully controlled studies are required to determine the precise benefits and cost-effectiveness of many of the expensive and often invasive interventions that are currently available.
